Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Randomized Trial of Aspirin on Recurrence and Survival in Colon Cancer
2017-001397-41Phase 3Active
- Sponsor
- Antwerp University Hospital
- Start
- May 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in colon cancer and colon adenocarcinoma comparing Aspirin 80 mg with Placebo (2 arms). Primary endpoint: 5-year Overall Survival. Started May 2017; status: active.
02
Drugs
aspirin
03
Conditions
colon cancercolon adenocarcinoma
Beyond the preview
Go deeper on 2017-001397-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001397-41.